Trans American Aquaculture (GRPS) FCF Margin (2023 - 2024)
Trans American Aquaculture (GRPS) reported FCF Margin of 25302.59% for Q4 2024, up 2558157.0% on a YoY basis from N/an in Q1 2024, and up 472.66% quarter-over-quarter from 6789.74% in Q2 2024.
Trans American Aquaculture (GRPS) FCF Margin (2023 - 2024) Analysis & Trends
Trans American Aquaculture has reported FCF Margin for 2 years, with the latest figure at 25302.59% in Q4 2024.
- For the quarter ending Q4 2024, FCF Margin rose 2558157.0% year-over-year to 25302.59%; the trailing twelve-month figure through Sep 2025 stood at 20629.18% (up 2080623.0% YoY), and the FY2024 full-year result was 1121.84%, up 222748.0% from the prior year.
- FCF Margin for Q4 2024 stood at 25302.59%, up from 6789.74% in the prior quarter.
- The five-year high for FCF Margin was 25302.59% in Q4 2024, with the low at 6789.74% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -429.96% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 32.62% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 13.24% |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 25,302.59% |
| Jun 30, 2024 | -6,789.74% |
| Mar 31, 2024 | -19.74% |
| Dec 31, 2023 | -278.97% |